Salud

In the aftermath of Hurricane Milton's devastating passage through Florida, significant relief comes from Daytona Beach, where a critical IV fluid manufacturing plant reported no damage. This facility, operated by B Braun Medical, is responsible for producing nearly a quarter of all IV fluids in the United States, a vital medical supply that was already dwindling due to recent storms in North Carolina. Before Milton made landfall, the facility had been identified as a crucial alternative source for these essential medical supplies. The importance of the Daytona Beach site increased following Hurricane Helene, which previously flooded a major IV fluid…

In response to the destructive aftermath of Hurricane Helene, U.S. authorities initiated emergency airlifts of intravenous (IV) fluids from international manufacturers to mitigate a critical shortage that led hospitals to postpone surgeries and prioritize critical patients. The crisis was exacerbated by extensive flooding in western North Carolina, which severely impacted a key Baxter plant responsible for producing approximately 60 percent of the IV fluids distributed across the country. These fluids are essential for a wide range of medical applications, including home dialysis, neonatal intensive care, and adults requiring nutritional support through tube feeding. The damage to the Baxter facility required…

Two American scientists, Victor Ambros and Gary Ruvkun, have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering work on microRNAs. This tiny molecule plays a vital role in regulating gene expression, influencing how organisms develop and function. Their research, using the nematode C. elegansrevealed a new level of complexity in the central dogma of molecular biology, demonstrating how microRNAs act as a control mechanism for protein production. This discovery has significant implications for understanding and treating disease. The regulatory function of microRNA can be disrupted in conditions such as cancer, diabetes and autoimmune diseases. The…

Rwanda has reported an outbreak of Marburg virus, a severe hemorrhagic fever known for its high mortality rate, with 11 fatalities this year. This marks the first appearance of the virus in Rwanda, located in east-central Africa, despite its presence in several other African nations in recent decades. Rwanda's Health Ministry has identified 36 cases since the virus was first detected in late September. In a related development, German health authorities have confirmed that two people suspected of having the Marburg virus have tested negative. The scare led to temporary restrictions at a major Hamburg train station, following symptoms the…

Rwanda is currently battling an epidemic of Marburg virus disease, a rare but serious hemorrhagic fever. Since the end of September, 36 cases and 11 deaths have been reported. Although caused by different viruses, Marburg shares similarities with Ebola in transmission, symptoms and progression. The virus is initially transmitted from fruit bats to humans. Previous outbreaks have occurred in Africa, but not in Rwanda. A medical student in Germany who had contact with an infected patient in Rwanda has shown symptoms. Tests confirmed negative for Marburg, reassuring the public that there is no current risk. First identified in 1967, Marburg…